Sirio Pharma's P/E ratio is typical for moderate growth expe...

Sirio Pharma's P/E ratio is typical for moderate growth expectations, but its superior earnings outlook isn't impacting its P/E as expected, indicating potential unseen threats to earnings. Investors anticipate future earnings volatility.